PSTI Insider Trading Activity and SEC Form 4 Filings
PSTI insider trading summary
No open-market insider purchases or sales of Pluristem Therapeutics Inc (PSTI) have been reported on SEC Form 4 in the past 12 months.
Latest PSTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 10, 2022 | Zami Aberman | Director | Buy | $145K (80,616 @ $1.80) |
| May 28, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $167K (45,000 @ $3.72) |
| May 28, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $260K (70,007 @ $3.72) |
| May 27, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $265K (71,775 @ $3.69) |
| May 27, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $89K (24,110 @ $3.69) |
| May 26, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $81K (22,015 @ $3.69) |
| May 26, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $451K (122,663 @ $3.68) |
| May 25, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $1.0M (261,238 @ $3.84) |
| May 24, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $304K (79,300 @ $3.83) |
| May 21, 2021 | Clover Wolf Capital - Limited Partnership | 10% Owner | Sell | $278K (69,838 @ $3.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.